Close Menu


Silicon Genetics has announced it will offer ArrayMiner, a clustering algorithm developed by Optimal Design of Brussels, Belgium, as an optional add-on with its GeneSpring software.

The potential successor to the microarray looks a lot like glitter. It s a handful of tiny silicon integrated circuits termed microtransponders, each smaller than the head of a pin. Each microtransponder contains 50 bits of memory, and transmits radio signals through a wispy antenna when activated by light.

Genomic Solutions has agreed to acquire arraying equipment maker Cartesian Technologies and cut its workforce 25 percent as part of an overall consolidation of operations.

PATENT WATCH: Sep 7, 2001


Yale Awarded Patent for Lizardi’s Multiple Strand Amplification Method



Alpha Innotech of San Leandro, Calif., has released Version 3.0 of AlphaEaseFC, its image analysis software.

Silicon Genetics has appointed Deepak Thakkar, formerly director of product management and market development at array analysis rival Rosetta Inpharmatics, as senior director of marketing.

Applied Precision of Issaqua, Wash., has signed an exclusive distribution partnership with Seki Technotron to market its arrayWoRxe Biochip Reader in Japan.


PhD in cytogenetics from Flemish University of Brussels, 1997.
Postdoctoral fellowship at Lawrence Livermore National Labs.

BioDiscovery has licensed its GeneSight microarray gene expression analysis software to the Torrey Mesa Research Institute, the genomics research arm of agrochemical giant Syngenta.

Third Wave Technologies and researchers from two academic centers in the US have applied the company s Invader genotyping technology to a microarray platform, the company said.


The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.